Among the many Syrians uprooted by armed conflict are thousands of people with chronic conditions – such as diabetes and heart disease - whose treatment was disrupted when they fled.

Novartis and Sangamo Therapeutics plan to pursue potential treatments for neurodevelopmental diseases.

A reversal in thinking about the reversibility of liver damage is changing the field of hepatology.

Bringing healthcare closer to where people live, work and shop can effectively tackle hypertension – the most deadly noncommunicable disease.

Novartis opens up a path of research to protect proteins that guard against cancer.

For a quarter of a century, Novartis and The Max Foundation have worked together to help people living with cancer in low- and middle-income countries access the care they need.

Learn about the career of our Global Medical Affairs Head for Solid Tumors and Rare Diseases.

A new compound aims to attack dangerous antibiotic-resistant bacteria.